Work

Extrachromosomal circular DNA (eccDNA) undergoes self-aggregation and phase separation with HOXD13 to confer chemotherapy resistance

Year: 2026
Type: preprint
Abstract: Extrachromosomal circular DNA (eccDNA) has emerged as a critical regulator driving malignant progression and therapeutic resistance in multiple cancers, yet its molecular mechanism remains poorly defined. Here, we demonstrate that eccDNA could undergo self-aggregation in vivo and in vitro , and interacted with HOXD13 protein. EccDNA promotes Esophageal Squamous Cell Carcinoma (ESCC) cell proliferation, migration, and cisplatin resistance by modulating HOXD13 condensate dynamics. Ectopic delivery of eccDNA restored cisplatin resistance in HOXD13-knockout ESCC cells, while depletion of HOXD13 abolished this phenotype. Functional assays including CCK-8, EDU incorporation and Transwell assays revealed that silencing HOXD13 markedly suppressed ESCC cell proliferation, DNA synthesis, and migratory capacity in vitro . Mechanistically, eccDNA or chemical cross-linking agents induced the formation of HOXD13 condensates, which distributed either the nucleus or cytoplasm. Screening of nucleocytoplasmic transport factors identified KPNB1 as the key importin mediating HOXD13 nuclear shuttling. Transcriptomic and CUT & Tag analysis revealed that eccDNA increased the immune response pathway and cancer signaling. In addition, we showed that eccDNA promoted the interaction of HOXD13 and NFκB. In xenograft mouse models, combined treatment with DNase I-mediated eccDNA clearance and cisplatin synergistically restrained tumor growth and elevated DNA damage compared with monotherapy. Collectively, our findings reveal a novel eccDNA-HOXD13 pathway that modulates ESCC malignancy and chemoresistance, highlighting eccDNA clearance as a promising strategy to improve the therapeutic efficacy of cisplatin in ESCC.
Language: English
Open Access status: green
OpenAlex ID: W7226023866
Cites: 27
Cited by:
Related to: 10